While EMT6 tumor‐bearing mice can also be effectively treated with combination chemotherapy (paclitaxel and anti‐VEGF), these mice do not display sterile immunity and are not protected from rechallenge with the same tumor, implying an ongoing susceptibility to metastatic recurrence 23. The gene discussed is VEGFA; the disease is neoplasm.